Sponsors
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Clinical Trials
A Whole New Class of Human Therapeutics
The pharmaceutical industry is more starved than ever for innovation – the most important strategy that every single pharmaceutical company relies on to grow and build their business.
Learn and Confirm
A new pharmaceutical environment has arrived – one that requires pharmaceutical companies to make the clinical development process more productive and efficient.
Clinical Trials
Vito Mangiardi, President of North American Operations at AAIPharma, and David Spaight, President of MDS Pharma, talk clinical trials, ethical standards, CROs and where the industry is heading.
The CRO
Mark P Clein, President and Co-Founder of the United BioSource Corporation, takes our eight questions challenge.
Company Focus: SpinX Technologies
Bart Van de Vyver, Ph.D, CEO, Piero Zucchelli, Ph.D., CSO and Michael Biros, Head of Sales, North America, provide insight to the industry’s excitement over SpinX Technologies’ unique approach to nanoliter-scale assay automation.
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.